SCHEMBL4424341

SCHEMBL4424341

c1ccc2cc(-c3cn4c(n3)SCC4)ccc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.70
MAPT P10636 9/20 0.70
MEN1 O00255 9/20 0.70
L3MBTL1 Q9Y468 2/20 0.70
TP53 P04637 1/20 0.70
GLA P06280 1/20 0.70
GAA P10253 2/20 0.66
POLB P06746 2/20 0.66
KDM4E B2RXH2 2/20 0.66
ALDH1A1 P00352 2/20 0.66
NSD2 O96028 1/20 0.66
ALPL P05186 1/20 0.66
ALPI P09923 1/20 0.66
ALPG P10696 1/20 0.66
G6PD P11413 1/20 0.66
HPGD P15428 1/20 0.66
NR4A1 P22736 1/20 0.66
APEX1 P27695 1/20 0.66
RECQL P46063 1/20 0.66
BLM P54132 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9742689 0.83 MAPT (1.00) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL13856561 0.79 MAPT (1.00) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL9742220 0.78 MAPT (0.63) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL9744862 0.77 MAPT (1.00) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL9744176 0.77 MAPT (0.72) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL11598254 0.75 MAPT (0.77) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL9738237 0.73 MAPT (0.67) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL14391902 0.73 MAPT (0.58) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL9743017 0.73 KMT2A (0.65) KMT2AMAPTMEN1L3MBTL1TP53
SCHEMBL5833790 0.72 KMT2A (0.52) KMT2AMAPTMEN1L3MBTL1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009154747-A1 PHARMACEUTICAL COMPOSITIONS GENZYME CORPORATION (US) 2009-12-23 WO disclosed
EP-0636247-A1 METHOD AND COMPOSITION FOR REDUCING THE EFFECTS OF ENDOGENOUS ALKALINE PHOSPHATASE DADE INTERNATIONAL INC. (US) 1995-02-01 EP disclosed
WO-1994019691-A1 METHOD AND COMPOSITION FOR REDUCING THE EFFECTS OF ENDOGENOUS ALKALINE PHOSPHATASE BAXTER DIAGNOSTICS INC. (US) 1994-09-01 WO disclosed